国际肝病：在中国促红细胞生成素的应用如何？
Hepatology Digest: What about in China and the use of erythropoietin?
关于促红细胞生成素- A (EPO - A)应用于创伤患者治疗急性期的现存临床证据仅14篇已发表文献。
The existing evidence on the early use of EPO-A in the acute phase of trauma patients management consists of only 14 publications.
促红细胞生成素是一种造血因子，临床中广泛应用于治疗各种原因造成的贫血。
Erythropoietin, the principal regulator of erythroids progenitor cells, is widely used to treat anemia caused by many diseases.
目的介绍红细胞生成素在早产儿的应用。
Objective: Introduce the application of erythropoietin to premature infants with anemia.
结果展示人类重组红细胞生成素在早产儿贫血中应用的剂量、方法、副作用。
Results: Show the dose, methods and side effects of recombinant human erythropoietin to premature infants with anemia.
应用促红细胞生成素(EPO)是目前治疗癌症及放、化疗相关性贫血的主要方法。
Using epoetin (epo) has become the major treatment regimen for patients with cancer -, radiotherapy - and chemotherapy-related anemia.
方法应用鲎法检查重组人红细胞生成素注射液中的细菌内毒素，考察重组人红细胞生成素注射液对细菌内毒素检查法的干扰。
METHODS Limulus reagent was used to detect pyrogen in recombinant human erythropoietin injection, to observe interference of recombinant human erythropoietin injection to bacterial endotoxin test.
本文重点讨论了重组人促红细胞生成素的临床应用及其检测。
This paper mainly discussed the clinic applications of rHuEPO and its detecting techniques.
红细胞生成素(EPO)在临床和基础研究中应用广泛。
Erythropoietin (EPO) is widely used in clinical and basic studies.
应用促红细胞生成素(EPO)是治疗非小细胞型肺癌在放、化疗相关性贫血的有效方法。
Using EPO to treat radiotherapy and chemotherapy relevant anemia in NSCLS is the effective method.
本文对近年来红细胞生成素在来源、分子结构、信号传导机制、生物学作用及临床应用等方面的研究进行了简单概述。
This paper introduces the recent development of research on its source, molecular structure, the mechanism of signal - transmitting, biological function and clinical application.
结论：促红细胞生成素可应用于急性肾功能衰竭患者的治疗，可以改善其预后，且短时间使用其严重不良反应罕见。
Conclusion: Erythropoietin could be used in ARF because it may improve patients' prognosis and no severe side effect was observed during its short-term administration.
结论：促红细胞生成素可应用于急性肾功能衰竭患者的治疗，可以改善其预后，且短时间使用其严重不良反应罕见。
Conclusion: Erythropoietin could be used in ARF because it may improve patients' prognosis and no severe side effect was observed during its short-term administration.
应用推荐